Wells Fargo & Company »

Avalyn Pharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $501k 15k 32.92

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Avalyn Pharma

FMR
Novo A/S
Sr One Capital Management
Perceptive Advisors
Suvretta Capital Management
NVP Associates
Wellington Management Company
Catalio Capital Management
Eventide Asset Management
Bellevue Group
BlackRock
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Andera Partners
Jennison Associates

View all funds holding Avalyn Pharma